Divi’s Laboratories, one of the largest active pharmaceutical ingredients (APIs) manufacturers in the world, gained more than 3 per cent per share on Thursday.

Cipla has settled its patent litigation with Celgene over the blockbuster cancer drug Revlimid. Celgene Corporation, a subsidiary of Bristol Myers Squibb, has agreed to provide Cipla with a licence to Celgene’s required patents. Cipla can then sell or manufacture certain volume-limited amounts of generic Lenalidomide in the United States sometime after March 2022.

A subsidiary of Biocon Limited i.e. Biocon Biologics and Mylan, a subsidiary of Viatris Inc., have received a positive opinion from European Medicines Agency's committee for medicinal products for human use (CHMP), recommending approval of the market authorisation of Kixelle, a biosimilar Insulin Aspart, which is rapid-acting insulin for the treatment of type 1 and 2 diabetes.

United States Food & Drug Administration (USFDA) has issued the first emergency use authorisation (EUA) as a vaccine for COVID-19.

Canara Bank Ltd, one of the largest public sector banks in India, is set to raise Rs 2,000 crore by way of qualified institutional placement (QIP). Reacting to the news, its stock gained 8 per cent on Tuesday.